PHE is collaborating with the Scottish, Welsh and Northern Ireland governments to produce the first UK-wide clinical guidelines for alcohol misuse.
Part three of this renal therapeutics CPPE module looks at chronic kidney disease, its causes and how to prevent its progression.
With sepsis awareness a focus of the CPCF, a new gateway page on the topic has been launched by CPPE.
This CPD module looks at antimicrobial resistance and the pharmacy team's role in tackling this patient safety threat.
European authorities have for the first time approved a cannabis-based medicine for use in severe childhood epilepsy.
A handheld device that delivers a small electric current has been recommended in draft guidance by NICE.
The new recommendations reduce the CVD risk threshold at which treatment for hypertension should be considered.
Sir Andrew Dillon has announced his intention to stand down as chief executive at the National Institute for Health and Care Excellence (NICE).
NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.
Pharmacists in all settings should be integrated into services aimed at preventing and managing type 2 diabetes.
NICE has published guidance covering how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with long-term conditions.
People with dementia should be involved in discussions about their care, says NICE in its latest guideline update for the condition.
NICE states that Cefaly, a device for the treatment and prevention of migraines, can safely be used within the NHS
NICE’s guidance will help care professionals “negotiate complex legislation and regulations”, says the body.